BamSEC and AlphaSense Join Forces
Learn More

Horizon Pharmaceutical LLC – Underwriting Agreements

Formerly NASDAQ: RPTP

Underwriting Agreements Filter

EX-1.1
from 8-K 38 pages Raptor Pharmaceutical Corp. $75,000,000 Sales Agreement
12/34/56
EX-1
from SC 13G/A 2 pages Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 35 pages Raptor Pharmaceutical Corp. 9,500,000 Shares Common Stock ($0.001 Par Value) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 38 pages Raptor Pharmaceutical Corp. $100,000,000 Amended and Restated Sales Agreement
12/34/56
EX-1.1
from 10-Q 2 pages Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
12/34/56
EX-1.1
from 8-K 38 pages Raptor Pharmaceutical Corp. $40,000,000 Sales Agreement
12/34/56
EX-1.1
from 8-K 40 pages 10,000,000 Shares Raptor Pharmaceutical Corp. Common Stock ($0.001 Par Value) Underwriting Agreement Dated September 8, 2011
12/34/56
EX-1.1
from 8-K 8 pages 3,747,558 Shares of Common Stock and Warrants to Purchase 3,747,558 Shares of Common Stock Raptor Pharmaceutical Corp. Placement Agent Agreement
12/34/56
EX-1
from SC 13D 1 page Joint Filing Agreement
12/34/56
EX-1.1
from SC 13G 1 page Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated July 21, 2003, (The "Schedule 13g"), With Respect to the Common Stock, Par Value $0.001 Per Share, of Axonyx Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 21st Day of July, 2003. Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member Orbimed Capital LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member By: /S/ Samuel D. Isaly Name: Samuel D. Isaly <page>
12/34/56
EX-1.1
from SC 13G 1 page Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated July 21, 2003, (The "Schedule 13g"), With Respect to the Common Stock, Par Value $0.001 Per Share, of Axonyx Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 21st Day of July, 2003. Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member Orbimed Capital LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member By: /S/ Samuel D. Isaly Name: Samuel D. Isaly <page>
12/34/56